CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients-Reference-Cited by-同舟云学术

CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients

Published:2019-06-27 Issue:3 Volume:105 Page:598-609
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Nasri Masoud,Ritter Malte,Mir Perihan,Dannenmann Benjamin,Aghaallaei Narges,Amend Diana,Makaryan Vahagn,Xu Yun,Fletcher Breanna,Bernhard Regine,Steiert Ingeborg,Hahnel Karin,Berger Jürgen,Koch Iris,Sailer Brigitte,Hipp Katharina,Zeidler Cornelia,Klimiankou Maksim,Bajoghli Baubak,Dale David C.,Welte Karl,Skokowa Julia

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications;Cytotherapy;2024-08

2. Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE: Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia;Journal of Pediatric Hematology/Oncology;2024-06-25

3. Neutrophils, an emerging new therapeutic platform;Current Opinion in Biotechnology;2024-06

4. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia;Molecular Therapy;2024-06

5. International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced;Cytotherapy;2024-06